#United States #New York #BYAH #Park Ha Tech #Xiaoyan Zhu

Class Action Lawsuit Against Park Ha Biological Technology Co.

In a significant development for investors, SueWallSt has alerted stakeholders of Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) about an ongoing securities class action lawsuit. Filed on behalf of shareholders who purchased BYAH securities between December 27, 2024, and July 8, 2025, this lawsuit raises critical questions regarding the company’s financial disclosures and operational integrity. The deadline for appointing a lead plaintiff is September 28, 2026.

Overview of the Lawsuit

The lawsuit emerges after Park Ha’s shares suffered a dramatic plunge of approximately 93%, collapsing from an intraday high of $41.49 on July 7, 2025, to a mere $2.99 on July 8, 2025. This swift decline obliterated over $1 billion in market capitalization, prompting investors to seek recourse through legal channels.

The complaint specifically targets Xiaoyan Zhu, who has served as Chief Financial Officer (CFO) since 2016 and joined the Board of Directors in mid-2024. It alleges that Zhu oversaw financial reporting that potentially obscured the truths behind the company’s promotional strategies and market manipulation tactics.

Claims Against Xiaoyan Zhu

Zhu is accused of being complicit in the purported omission of critical details that left BYAH stock vulnerable to manipulation. Key allegations include:

• - Zhu signed various registration statements that included misleading information regarding BYAH’s earnings and franchise revenue.
• - The statement revealed a gross profit margin of 93%, while neglecting to inform investors about the extensive influence of a low public float and the presence of deceptive financial advice circulating amongst potential investors on platforms like WhatsApp.
• - The lawsuit contends that Zhu, as CFO, had intimate knowledge of the company's financial dynamics yet failed to rectify risky disclosures that could mislead investors.

Legal Implications

The legal framework of the complaint cites multiple sections under the Securities Act and Exchange Act, suggesting that if the allegations are substantiated, Zhu and other implicated officers could face personal liability for the alleged misstatements in offering documents. Joseph E. Levi, the attorney representing the class action, emphasized that individual officers bear personal responsibility for corporate disclosures and noted that BYAH's offering materials framed risks associated with low float volatility only as a speculative theory.

What Investors Should Know

For those affected, understanding the implications of this class action is crucial. Investors interested in potentially recovering losses must meet eligibility criteria based on their purchase of BYAH shares during the specified period. Critical updates and details on participation can be obtained by contacting SueWallSt at the provided phone number or email address.

FAQ Section on BYAH Lawsuit

A section of frequently asked questions offers clarity to investors on the specifics of the lawsuit, elucidating details about:

• - Defendants: The class action includes key figures such as Xiaoqiu Zhang, founder and CEO, and other senior executives alongside Park Ha itself.
• - Misstatements: Allegations focus on multiple inaccuracies associated with BYAH’s business operations and fraud schemes tied to share trading.
• - Court Details: The action was initiated in the U.S. District Court for the Southern District of New York, adhering to the dictates of the Private Securities Litigation Reform Act of 1995.

Importantly, even past investors who have since sold their shares may still be eligible to participate in any recovery effort.

The growing interest surrounding this case reflects a critical opportunity for shareholders to reclaim potential losses amidst significant turbulence in Park Ha’s trading history. For a comprehensive understanding of your rights as an investor, consider reaching out to legal experts for personalized guidance.

Stay informed by following developments regarding this pivotal case, as the repercussions could resonate through the investor community for some time to come.